New England Biolabs Executive and Leadership Team

Salvatore Russello, the Chief Executive Officer at New England Biolabs, directs the company's overall strategic vision and operational execution. Overseeing all major business units, Russello ensures alignment with the company's mission to support life science research through high-quality enzyme reagents and innovative solutions. This leadership role involves guiding product development, market expansion, and fostering a culture of scientific excellence. By driving strategic initiatives, Salvatore Russello ensures New England Biolabs maintains its position as a leader in recombinant and native enzyme production, supporting advancements in genome editing, synthetic biology, and next-generation sequencing. The Chief Executive Officer's purview extends to managing key partnerships and ensuring the company's long-term financial health and sustainable growth, directly impacting the global research community.

Richard Ireland, the Chief Financial Officer at New England Biolabs, manages all financial operations and strategic financial planning. Overseeing accounting, budgeting, and financial reporting, Ireland ensures fiscal responsibility and drives profitability across the organization. This critical role involves analyzing market trends, managing investment strategies, and optimizing resource allocation to support the company's growth in recombinant and native enzyme reagents. By maintaining robust financial controls, Richard Ireland safeguards the company's assets and supports its mission to provide essential tools for life science research, including genome editing and next-generation sequencing. The Chief Financial Officer's expertise is vital for securing funding, managing cash flow, and ensuring the long-term economic viability of New England Biolabs' operations.

Hiroshi Toshishige, the Neb Inc President & General Manager (Japan) at New England Biolabs, spearheads the company's strategic initiatives and operational management within the Japanese market. Overseeing all business functions in Japan, Toshishige drives market penetration and customer engagement for recombinant and native enzyme reagents. This executive role involves adapting global strategies to local market needs, ensuring compliance with regional regulations, and fostering strong relationships with research institutions and industry partners. By leading the Japanese division, Hiroshi Toshishige expands New England Biolabs' global reach, supporting advancements in genome editing and synthetic biology across Asia. The President & General Manager's leadership ensures the effective delivery of cutting-edge solutions to the Japanese scientific community.

Lennox Brown, the Chief Information Officer & Director, Information Technology at New England Biolabs, architects and oversees the company's entire technology infrastructure and digital strategy. Managing all IT operations, Brown ensures the seamless integration of systems that support research, development, and global distribution of enzyme reagents. This leadership position involves driving innovation in data management, cybersecurity, and IT support to enhance operational efficiency and scientific discovery. By implementing advanced technological solutions, Lennox Brown empowers researchers with access to vital tools like REBASE and InBASE, facilitating breakthroughs in synthetic biology and next-generation sequencing. The Chief Information Officer's focus on robust IT systems directly supports New England Biolabs' commitment to providing reliable solutions for the life science community worldwide.